Andrew Obenshain insider trades: bluebird bio (BLUE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Andrew reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | BLUE | ↓ Sell | 921 | $3.92 | $4K | Direct | Mar 5, 2025 (2d) |
| Feb 3, 2025 | BLUE | ↓ Sell | 86 | $7.39 | $636 | Direct | Feb 5, 2025 (2d) |
| Jan 6, 2025 | BLUE | ↓ Sell | 140 | $9.24 | $1K | Direct | Jan 8, 2025 (2d) |
| Dec 10, 2024 | BLUE | ↓ Sell | 971 | $0.42 | $405 | Direct | Dec 12, 2024 (2d) |
| Sep 30, 2024 | BLUE | ↓ Sell | 34,780 | $0.53 | $18K | Direct | Oct 2, 2024 (2d) |
| Mar 4, 2024 | BLUE | ↓ Sell | 6,095 | $1.53 | $9K | Direct | Mar 5, 2024 (1d) |
| Feb 5, 2024 | BLUE | ↓ Sell | 1,879 | $0.90 | $2K | Direct | Feb 6, 2024 (1d) |
| Jan 5, 2024 | BLUE | ↓ Sell | 3,162 | $1.43 | $5K | Direct | Jan 9, 2024 (4d) |
| Nov 3, 2023 | BLUE | ↓ Sell | 807 | $3.17 | $3K | Direct | Nov 3, 2023 (0d) |
| Aug 10, 2023 | BLUE | ↓ Sell | 16,929 | $3.54 | $60K | Direct | Aug 10, 2023 (0d) |
| Jan 11, 2023 | BLUE | ↓ Sell | 3,178 | $7.80 | $25K | Direct | Jan 13, 2023 (2d) |
| Nov 4, 2022 | BLUE | ↓ Sell | 1,263 | $6.41 | $8K | Direct | Nov 8, 2022 (4d) |
| Aug 4, 2022 | BLUE | ↓ Sell | 21,805 | $4.39 | $96K | Direct | Aug 8, 2022 (4d) |
| Jan 11, 2022 | BLUE | ↓ Sell | 7,725 | $9.53 | $74K | Direct | Jan 12, 2022 (1d) |
| Dec 7, 2021 | BLUE | ↓ Sell | 832 | $10.18 | $8K | Direct | Dec 9, 2021 (2d) |
| Jun 4, 2021 | BLUE | ↓ Sell | 511 | $30.75 | $16K | Direct | Jun 8, 2021 (4d) |
| May 3, 2021 | BLUE | ↓ Sell | 29 | $30.15 | $874 | Direct | May 5, 2021 (2d) |
| Apr 5, 2021 | BLUE | ↓ Sell | 29 | $30.21 | $876 | Direct | Apr 7, 2021 (2d) |
| Mar 2, 2021 | BLUE | ↓ Sell | 34 | $29.58 | $1K | Direct | Mar 4, 2021 (2d) |
| Feb 17, 2021 | BLUE | ↓ Sell | 749 | $28.16 | $21K | Direct | Feb 18, 2021 (1d) |
| Feb 2, 2021 | BLUE | ↓ Sell | 34 | $45.93 | $2K | Direct | Feb 4, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Andrew Obenshain's insider trades
Andrew Obenshain is President and CEO at bluebird bio (BLUE). Since Feb 2, 2021, Andrew has reported no open-market purchases and 21 sales worth $354K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings), other transactions (2 filings), shares returned to the company (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BLUE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.